Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00178282 · ClinicalTrials.gov registry record · NA
Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence
A NA study, sponsored by University of Rochester.
- Terminated
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT00178282: Clinical Trial NA study, sponsored by University of Rochester.
NCT00178282 is a NA study that was terminated before completion, run by University of Rochester. The registered enrollment target is 23 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00178282, a NA study, was terminated before completion, sponsored by University of Rochester.
- TERMINATED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if pelvic exercises can reduce the occurrence of urinary incontinence (involuntary loss of urine) before and after delivery. We would also like to see if performing pelvic exercises before birth has an effect on labor and/or delivery, and if there are any specific characteristics for developing urinary incontinence during pregnancy and after delivery.
Interventions
- PROCEDURE Pelvic Floor Muscle exercises
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2005-06 |
| Est. Completion | 2007-10 |
| Phase | NA |
Why NCT00178282 stopped before completion
NCT00178282 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 23 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Pelvic Floor Muscle exercises is the first listed.
NCT00178282 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00178282 about?
NCT00178282 is a clinical study titled "Low-Intensity Physical Therapy for Prevention of Pre and Postpartum Urinary Incontinence". The purpose of this study is to determine if pelvic exercises can reduce the occurrence of urinary incontinence (involuntary loss of urine) before and after delivery. We would also like to see if performing pelvic exercises before birth has an effect on labor and/or delivery, and if there are any sp...
What is the current status of trial NCT00178282?
This trial is currently terminated. It is a NA study. The enrollment target is 23 participants. The study started on 2005-06. Estimated completion is 2007-10.
What interventions are being tested in trial NCT00178282?
The interventions under investigation include: Pelvic Floor Muscle exercises (PROCEDURE).
Who is sponsoring clinical trial NCT00178282?
This trial is sponsored by University of Rochester, which has 636 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00178282's enrollment target sits among peer trials
23 1755th of 2000 higher than 245 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03616041 · 23 participants
Capsule Endoscopy for Severe Hematochezia
- NCT04348747 · 23 participants · Phase 2
Dendritic Cell Vaccines Against Her2/Her3 and Pembrolizumab for the Treatment of Brain Metastasis From Triple Negative Breast Cancer or HER2+ Breast Cancer
- NCT04587687 · 23 participants · Phase 2
Brentuximab Vedotin and Bendamustine for the Treatment of Relapsed or Refractory Follicular Lymphoma
- NCT04715022 · 23 participants · Phase 1
Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia